Cover Image
Market Research Report

Avascular Necrosis Market - Size, Share, Trends, and Forecast to 2026

Published by Coherent Market Insights Product code 738726
Published Content info 147 Pages
Delivery time: 2-3 business days
Price
Back to Top
Avascular Necrosis Market - Size, Share, Trends, and Forecast to 2026
Published: October 10, 2018 Content info: 147 Pages
Description

Avascular necrosis (AVN), also called osteonecrosis, ischemic bone necrosis, or aseptic necrosis, is a condition that occurs due to loss of blood flow to the bone. The condition mostly occurs in the hip however, other common sites include ankle, knee, and shoulder. Individuals between the age of 20 and 50 years are more susceptible to avascular necrosis. Most cases of avascular necrosis occur due to an underlying health problem or injury. Moreover, factors such as increased intake of corticosteroids and alcohol may cause fatty substances to build in the blood vessels and decrease the blood supply to the bones, eventually causing avascular necrosis. Treatment for this condition depends on a number of factors, including age, disease stage, location, and amount of bone damage.

Market Dynamics

Growth of avascular necrosis market is primarily driven by factors such as increasing incidence of avascular necrosis, high demand for non-invasive treatment, and increasing dependence on surgery to cure avascular necrosis. According to Bone Therapeutics report in 2017, around 170,000 patients were suffering from avascular necrosis in the U.S., Europe, and Japan. Moreover, side effects from various medicines taken during cancer, HIV/AIDS, osteoporosis, osteoarthritis, blood disorders, or medical treatment such as chemotherapy, radiation therapy, high-dosage of steroids, and organ transplants can increase chances of developing avascular necrosis. However, delay in diagnosis due to asymptomatic nature of this condition at early stage and high cost of surgical treatments for avascular necrosis are the major factors hampering growth of the avascular necrosis market.

Key features of the study:

This report provides in-depth analysis of the avascular necrosis market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players

It profiles key players in the global avascular necrosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global avascular necrosis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for avascular necrosis products, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Avascular Necrosis Market, By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • Global Avascular Necrosis Market, By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Global Avascular Necrosis Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Type:
  • Trauma Related Avascular Necrosis
  • Non-Trauma Related Avascular Necrosis
  • By Treatment:
  • Drug Based
  • Surgery
  • Core decompression surgery
  • Osteotomy
  • Bone graft
  • Total joint replacement
  • Company Profiles
  • Bone Therapeutics*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Enzo Biochem Inc.
  • Ethicon Inc.
  • Eli Lilly and Company
  • Grifols SA
  • Integra LifeSciences Corporation
  • K-Stemcell Co Ltd.
  • Medtronic Plc
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Epidemiology Analysis
  • PEST Analysis
  • Pipeline Analysis

4. Global Avascular Necrosis Market, By Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Trauma Related Avascular Necrosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Non-Trauma Related Avascular Necrosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Avascular Necrosis Market, By Treatment, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Drug-Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Surgery-Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Core decompression surgery
    • Osteotomy
    • Bone graft
    • Total joint replacement

6. Global Avascular Necrosis Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Bone Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Enzo Biochem Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Ethicon Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Grifols SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Integra LifeSciences Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • K-Stemcell Co Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medtronic Plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sanofi SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Wright Medical Group N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zimmer Biomet Holdings
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top